EUVIMEDEUVIMED entdecken
Open Access

Levamisole in opioid overdose patients: An evolving adulterant landscape

Alyssa M Falise, Jennie Buchanan, Rachel Culbreth, Michael Levine, Evan Schwarz, Kim Aldy, Sharan Campleman, Alex Krotulski, Jeffrey Brent, Paul Wax, Will Goodrich, Alex F Manini und 1 weitere

Addictive Behaviors · 2026-07 · 178 · 108671

DOI: 10.1016/j.addbeh.2026.108671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addictive Behaviors, 2026-07. Verfasst von Alyssa M Falise und 12 weiteren Autor:innen. Beteiligte Einrichtung: American College of Medical Toxicology, Phoenix, AZ, United States. Electronic address: Alyssa.Falise@acmt.net. Hauptthemen laut MEDLINE: Levamisole, Drug Contamination, Opiate Overdose, Opioid-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Levamisole is an adulterant commonly associated with cocaine and has remained in the United States illicit drug supply despite a national decline in cocaine use. Levamisole has recently been detected in seized illicit opioid samples, but limited research exists on this drug combination. This study examined the prevalence of laboratory confirmed levamisole exposures among patients with opioid overdose and assessed its association with sociodemographic characteristics along with patterns of co-occurring substance use. METHODS: This secondary data analysis of the Toxicology Investigators Consortium (ToxIC) Fentalog Study examined patients presenting to any of ten participating emergency departments throughout the United States with a suspected opioid overdose between 2020-2024. Chart reviews were conducted, and waste serum samples underwent liquid chromatography quadrupole time-of-flight mass spectroscopy for comprehensive toxicology analysis. This secondary analysis only included patients who had confirmed opioid exposure at the time of overdose. RESULTS: Of 1,678 patients with confirmed opioid use, 225 (13.4%) were levamisole positive. Levamisole was more commonly detected in females (34.2%) compared to males (25.5%, p < 0.01), and there were significant age-related and racial/ethnic differences. Levamisole exposure was associated with a significantly higher number of confirmed co-exposures (levamisole: median = 9 substances, no levamisole: median = 6 substances, p < 0.01). It was also more frequently detected with stimulants (p < 0.01), fentanyl, and fentanyl analogues such as butyrylfentanyl, N-methyl-norfentanyl, ortho-fluorofentanyl, and para-flurorofentanyl (p < 0.05). CONCLUSIONS: More than one in eight patients presenting with an opioid overdose were exposed to levamisole. These findings provide potential new evidence for levamisole adulteration alongside fentanyl and its analogues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevamisoleDrug ContaminationOpiate OverdoseOpioid-Related DisordersDrug OverdoseHumansMaleFemaleAdultUnited StatesMiddle AgedCocaineYoung AdultAnalgesics, Opioid

Stichwörter der Autor:innen

CocaineLevamisoleMedical toxicologyOpioidsOverdose

Substanzen

LevamisoleCocaineAnalgesics, Opioid

Autor:innen und Institutionen

  • American College of Medical Toxicology, Phoenix, AZ, United States. Electronic address: Alyssa.Falise@acmt.net.
  • Division of Medical Toxicology, Department of Emergency Medicine, Denver Health and Hospital Authority, Denver, CO, United States.
  • American College of Medical Toxicology, Phoenix, AZ, United States.
  • Department of Emergency Medicine, University of California-Los Angeles, Los Angeles, CA, United States.
  • American College of Medical Toxicology, Phoenix, AZ, United States; Department of Emergency Medicine, Baylor University Medical Center, Dallas, TX, United States.
  • Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, PA, United States.

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse
  • Centers for Disease Control and Prevention
  • University of Pittsburgh
  • Icahn School of Medicine at Mount Sinai
  • School of Medicine, Emory University
  • Morsani College of Medicine
  • National Institutes of Health

Zitieren

APA

Falise, A. M., Buchanan, J., Culbreth, R., Levine, M., Schwarz, E., Aldy, K., Campleman, S., Krotulski, A., Brent, J., Wax, P., Goodrich, W., Manini, A. F., & Toxicology Investigators Consortium ToxIC Fentalog Study Group (2026). Levamisole in opioid overdose patients: An evolving adulterant landscape. Addictive Behaviors, 178, 108671. https://doi.org/10.1016/j.addbeh.2026.108671

Vancouver

Falise AM, Buchanan J, Culbreth R, Levine M, Schwarz E, Aldy K, et al. Levamisole in opioid overdose patients: An evolving adulterant landscape. Addictive Behaviors. 2026;178:108671. doi:10.1016/j.addbeh.2026.108671

BibTeX
@article{Falise2026,
  author = {Falise, Alyssa M and Buchanan, Jennie and Culbreth, Rachel and Levine, Michael and Schwarz, Evan and Aldy, Kim and Campleman, Sharan and Krotulski, Alex and Brent, Jeffrey and Wax, Paul and Goodrich, Will and Manini, Alex F and Toxicology Investigators Consortium ToxIC Fentalog Study Group, Toxicology Investigators Consortium ToxIC Fentalog Study Group},
  title = {Levamisole in opioid overdose patients: An evolving adulterant landscape},
  journal = {Addictive Behaviors},
  year = {2026},
  volume = {178},
  pages = {108671},
  doi = {10.1016/j.addbeh.2026.108671}
}
Kostenlos starten →